Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia.
Controlled study in people · 1987
- What was studied
- 14 middle-aged patients with chronic insomnia
- Main finding
- A 14-person placebo-controlled insomnia report described improved sleep and daytime performance over seven nights of DSIP, without giving numerical sleep or performance effect sizes in its abstract.
Reported findings and study design
A 14-person placebo-controlled insomnia report described improved sleep and daytime performance over seven nights of DSIP, without giving numerical sleep or performance effect sizes in its abstract.
14 middle-aged chronic insomniacs; double-blind placebo-controlled administration and polysomnography.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Sleep and daytime performance | Reported improvements; numerical changes not supplied | Sleep effects reportedly persisted on the first placebo post-treatment night |
| Participants | 14 chronic-insomnia patients | |
| Observation schedule | 7 successive treatment nights; daytime testing before and after 6 injections |
This positive report is shown alongside the separate weak/neutral DSIP comparisons; their findings should not be pooled without full methods.
Source for these results ↗ · Reviewed 2026-11-01
Study limitations and source details
Study limitations
- Small sample and short follow-up; allocation and complete methods require appraisal.
Source details
Indexed metadata and abstract checked via PubMed / Europe PMC; full methods and risk-of-bias assessment pending.
Sources checked
Citation
Schneider-Helmert D. Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia. European neurology 27(2):120-129
Study source ↗ · DOI 10.1159/000116143 · Bibliography entry · Link to this summary